Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Human Vaccines & Immunotherapeutics|March 6, 2024
Factors influencing adverse events following COVID-19 vaccinationPaola Villanueva, Ellie McDonald, Julio Croda, et al.
Journal of Water and Health|November 29, 2023
First report of Acanthamoebae spp. isolation from a volcanic mud spring in the PhilippinesCrisselle Marie Celis, Isabella Marie Caburnay, Fritz Irish Avila, et al.
British Journal of Cancer|January 12, 2024
Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancerChui Yan Mah, An Dieu Trang Nguyen, Takuto Niijima, et al.
Elife|August 12, 2021
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growthJoanna L Gillis, Josephine A Hinneh, Natalie K Ryan, et al.
The Journal of Infection|August 14, 2024
Exposure to doxycycline increases risk of carrying a broad range of enteric antimicrobial resistance determinants in an elderly cohortLucy Carpenter, Sophie Miller, Erin Flynn, et al.
Scientific Reports|February 3, 2018
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasionHeather K Armstrong, Joanna L Gillis, Ian R D Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar TyphiLucinda J Thompson, Sarah J Dunstan, Christiane Dolecek, et al.
Plos One|March 7, 2017
Whole exome sequencing implicates eye development, the unfolded protein response and plasma membrane homeostasis in primary open-angle glaucomaTiger Zhou, Emmanuelle Souzeau, Shiwani Sharma, et al.
Elife|July 21, 2020
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosisZeyad D Nassar, Chui Yan Mah, Jonas Dehairs, et al.
Cell Reports. Medicine|January 14, 2022
The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiotaStephen J Blake, Jane James, Feargal J Ryan, et al.
Pageof 15